| Cat. No. |
Product Name |
Information |
| PC-45527 |
APNEA
A3AR agonist
|
APNEA is a non-selective agonist of adenosine A3 receptor, has a high affinity for the adenosine A1 and A3 receptors. |
| PC-45624 |
AB-MECA
A3AR agonist
|
AB-MECA is a high affinity A3 adenosine receptor (A3AR) agonist with binding Ki of 430.5 nM for human A3 receptors in CHO cells. |
| PC-22012 |
CVT-7124
A2B adenosine receptor inhibitor
|
CVT-7124 (CVT7124) is a highly potent, selective A2B adenosine receptor antagonist with Ki of 6 nM (hA2B), >830-fold selective over A1, A2A and A3 receptors. |
| PC-21511 |
MRS7469
A1AR agonist
|
MRS7469 is a potent and selective orthosteric A1 adenosine receptor (A1AR) agonist with Ki of 2.14 nM, >2000-fold selective for A1AR over other adenosine receptors. |
| PC-20644 |
VUF-5574
A3 adenosine antagonist
|
VUF-5574 (VUF5574) is a potent, selective A3 adenosine receptor antagonist with high affinity (Ki=4.03 nM, human A3 receptor). |
| PC-20643 |
OT-7999
A3 adenosine antagonist
|
OT-7999 (OT7999) is a potent and selective adenosine A3 receptor antagonist with Ki of 0.61 nM (human A3 receptor) in radioligand binding assays. |
| PC-20641 |
MRS1191
A3 adenosine antagonist
|
MRS1191 (MRS-1191) is a potent and selective A3 adenosine receptor antagonist with Ki of 32 nM, shows no acitivity against A2A, A2B, A1 receptors (Ki>10 uM). |
| PC-20110 |
SCH-442416
A2AR antagonist
|
SCH-442416 (SCH442416) is a potent, selective and brain-penetrant antagonist of adenosine A2A receptor (A2AR) with Ki 0.048 nM and 0.5 nM for human and rat A2AR, respectively. |
| PC-38488 |
CGS-15943
Adenosine receptor inhibitor
|
CGS-15943 is a potent, non-xanthine adenosine receptor antagonist with Ki values of 3.5, 4.2, 16 and 51 nM for human A1, A2A, A2B and A3 receptors respectively. |
| PC-38365 |
Inupadenant
A2AR antagonist
|
Inupadenant (EOS-850, EOS100850) is a non brain-penetrant, potent and highly selective small molecule antagonist of adenosine A2a receptor (A2AR), shows activity at the high adenosine concentrations found in tumors. |
